|
With all the available information, in the absence of the devices being returned, the reported event of patient experiencing undesired stimulation sensations is a known inherent risk with use of the devices, as documented in the instructions for use (ifu).A review of the manufacturing documentation for the dbs devices revealed that no anomalies or deviations related to the event occurred during manufacturing.The devices were retained by the facility and not returned for analysis; therefore, a physical analysis has not been conducted in our laboratory.However, labeling review was conducted.A product labeling review identified that the devices were used per the ifu product labels.Additionally, undesirable stimulation may occur over time due to cellular changes in tissue around the electrodes, changes in electrode position, loose electrical connections and/or lead failure, all of which are noted within the ifu as known inherent risks associated with use of the devices.The dbs devices were retained by the facility and not returned.As such, physical analysis has not been conducted in our laboratory.However, the labeling review was conducted.With the reported observations and the labeling review, it has been determined that undesired stimulation sensations is a known inherent risk with use of the devices as documented in the ifu.Additional suspect medical device components involved in the event: product family: dbs-linear leads, upn: m365db220145dc0, model: db-2201-45dc, serial: (b)(6), batch: 679210, udi: (b)(4).Product family: dbs-lead fixation, upn: m365db4600c0, model: db-4600-c, serial: n/a, batch: 21964610, udi: (b)(4).
|